PRTX

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 9/08/2016
Contact Info
  • 131 Columbia Turnpike
  • Suite 1
  • Florham Park, NJ 07932

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Aug 31, 2016 10-Q
CIK 0001099215
Fiscal Year End 5/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 8731 - Commercial physical research
Business Status Development Stage Company a/o
Incorporated In: DE, USA
Year of Inc. 1999
Employees 3 a/o Jul 01, 2016
Company Officers/Contacts
Arnold P. Kling President
Kirk M. Warshaw CFO
Company Directors
Marco M. Elser
Arnold P. Kling
Kirk M. Warshaw
Company Notes
  • Note=12-04 State of Incorporation New Mexico changed to Delaware
  • Note=3-31-05 company is in the development stage, formed to fully develop and bring to commercial realization certain bioregulator technology to treat human diseases
  • Formerly=Enerdyne Corp. until 1-00
Service Providers
Accounting/Auditing Firm
Liggett & Webb, P.A.
432 Park Avenue South, 10 Floor
New York, NY, 10016
United States

Legal Counsel
Morse, Zelnick, Rose & Lander, LLP
825 3rd Avenue
New York, NY, 10022
United States

Investor Relations Firm
Lippert/Heilshorn & Associates
800 Third Avenue
17th Floor
New York, NY, 10022
United States

PRTX Security Details
Share Structure
Market Value1 $43,151,373 a/o Dec 02, 2016
Authorized Shares 100,000,000 a/o Jul 15, 2016
Outstanding Shares 28,767,582 a/o Oct 14, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 6,152,433 a/o May 31, 2016
Par Value 0.00001
Shareholders
Shareholders of Record 252 a/o Jul 15, 2016
Short Selling Data
Short Interest 1,700 (6.05%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security